Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

iPS cell sheets created by a novel magnetite tissue engineering method for reparative angiogenesis.

Kito T, Shibata R, Ishii M, Suzuki H, Himeno T, Kataoka Y, Yamamura Y, Yamamoto T, Nishio N, Ito S, Numaguchi Y, Tanigawa T, Yamashita JK, Ouchi N, Honda H, Isobe K, Murohara T.

Sci Rep. 2013;3:1418. doi: 10.1038/srep01418.

2.

Enhanced angiogenesis by transplantation of mesenchymal stem cell sheet created by a novel magnetic tissue engineering method.

Ishii M, Shibata R, Numaguchi Y, Kito T, Suzuki H, Shimizu K, Ito A, Honda H, Murohara T.

Arterioscler Thromb Vasc Biol. 2011 Oct;31(10):2210-5. doi: 10.1161/ATVBAHA.111.231100. Epub 2011 Jul 14.

3.

Therapeutic angiogenesis by transplantation of induced pluripotent stem cell-derived Flk-1 positive cells.

Suzuki H, Shibata R, Kito T, Ishii M, Li P, Yoshikai T, Nishio N, Ito S, Numaguchi Y, Yamashita JK, Murohara T, Isobe K.

BMC Cell Biol. 2010 Sep 22;11:72. doi: 10.1186/1471-2121-11-72.

4.

Multilayered adipose-derived regenerative cell sheets created by a novel magnetite tissue engineering method for myocardial infarction.

Ishii M, Shibata R, Shimizu Y, Yamamoto T, Kondo K, Inoue Y, Ouchi N, Tanigawa T, Kanemura N, Ito A, Honda H, Murohara T.

Int J Cardiol. 2014 Aug 20;175(3):545-53. doi: 10.1016/j.ijcard.2014.06.034. Epub 2014 Jul 2.

PMID:
25023793
5.

Comparative angiogenic activities of induced pluripotent stem cells derived from young and old mice.

Suzuki H, Shibata R, Kito T, Yamamoto T, Ishii M, Nishio N, Ito S, Isobe K, Murohara T.

PLoS One. 2012;7(6):e39562. doi: 10.1371/journal.pone.0039562. Epub 2012 Jun 27.

6.

Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.

Yu JX, Huang XF, Lv WM, Ye CS, Peng XZ, Zhang H, Xiao LB, Wang SM.

J Vasc Surg. 2009 Sep;50(3):608-16. doi: 10.1016/j.jvs.2009.05.049. Epub 2009 Jul 12.

7.

Deletion of FHL2 gene impaired ischemia-induced blood flow recovery by modulating circulating proangiogenic cells.

Huang PH, Chen CY, Lin CP, Wang CH, Tsai HY, Lo WY, Leu HB, Chen JW, Lin SJ, Chu PH.

Arterioscler Thromb Vasc Biol. 2013 Apr;33(4):709-17. doi: 10.1161/ATVBAHA.112.300318. Epub 2013 Feb 14.

8.

Bone tissue engineering with human mesenchymal stem cell sheets constructed using magnetite nanoparticles and magnetic force.

Shimizu K, Ito A, Yoshida T, Yamada Y, Ueda M, Honda H.

J Biomed Mater Res B Appl Biomater. 2007 Aug;82(2):471-80.

PMID:
17279563
9.

The effect of RGD peptide-conjugated magnetite cationic liposomes on cell growth and cell sheet harvesting.

Ito A, Ino K, Kobayashi T, Honda H.

Biomaterials. 2005 Nov;26(31):6185-93.

PMID:
15899515
10.

Therapeutic reendothelialization by induced pluripotent stem cells after vascular injury--brief report.

Yamamoto T, Shibata R, Ishii M, Kanemura N, Kito T, Suzuki H, Miyake H, Maeda K, Tanigawa T, Ouchi N, Murohara T.

Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2218-21. doi: 10.1161/ATVBAHA.113.301313. Epub 2013 Jul 18.

11.

Human adipose tissue-derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia.

Moon MH, Kim SY, Kim YJ, Kim SJ, Lee JB, Bae YC, Sung SM, Jung JS.

Cell Physiol Biochem. 2006;17(5-6):279-90. Epub 2006 Jun 20.

12.

The therapeutic effect of vascular endothelial growth factor gene- or heme oxygenase-1 gene-modified endothelial progenitor cells on neovascularization of rat hindlimb ischemia model.

Long J, Wang S, Zhang Y, Liu X, Zhang H, Wang S.

J Vasc Surg. 2013 Sep;58(3):756-65.e2. doi: 10.1016/j.jvs.2012.11.096. Epub 2013 Apr 4.

13.

Genetically engineered angiogenic cell sheets using magnetic force-based gene delivery and tissue fabrication techniques.

Akiyama H, Ito A, Kawabe Y, Kamihira M.

Biomaterials. 2010 Feb;31(6):1251-9. doi: 10.1016/j.biomaterials.2009.11.017. Epub 2009 Nov 25.

PMID:
19942286
14.

Efficient preparation and labeling of human induced pluripotent stem cells by nanotechnology.

Ruan J, Shen J, Wang Z, Ji J, Song H, Wang K, Liu B, Li J, Cui D.

Int J Nanomedicine. 2011;6:425-35. doi: 10.2147/IJN.S16498. Epub 2011 Feb 21.

15.

Therapeutic angiogenesis using tissue engineered human smooth muscle cell sheets.

Hobo K, Shimizu T, Sekine H, Shin'oka T, Okano T, Kurosawa H.

Arterioscler Thromb Vasc Biol. 2008 Apr;28(4):637-43. doi: 10.1161/ATVBAHA.107.151829. Epub 2008 Jan 17.

16.

Far infra-red therapy promotes ischemia-induced angiogenesis in diabetic mice and restores high glucose-suppressed endothelial progenitor cell functions.

Huang PH, Chen JW, Lin CP, Chen YH, Wang CH, Leu HB, Lin SJ.

Cardiovasc Diabetol. 2012 Aug 15;11:99. doi: 10.1186/1475-2840-11-99.

17.

Construction and delivery of tissue-engineered human retinal pigment epithelial cell sheets, using magnetite nanoparticles and magnetic force.

Ito A, Hibino E, Kobayashi C, Terasaki H, Kagami H, Ueda M, Kobayashi T, Honda H.

Tissue Eng. 2005 Mar-Apr;11(3-4):489-96.

PMID:
15869427
18.

Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb.

Silvestre JS, Tamarat R, Senbonmatsu T, Icchiki T, Ebrahimian T, Iglarz M, Besnard S, Duriez M, Inagami T, Lévy BI.

Circ Res. 2002 May 31;90(10):1072-9.

19.

Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice.

Moriya J, Wu X, Zavala-Solorio J, Ross J, Liang XH, Ferrara N.

J Vasc Surg. 2014 May;59(5):1402-9.e1-4. doi: 10.1016/j.jvs.2013.04.053. Epub 2013 Jul 13.

20.

Therapeutic angiogenesis by ex vivo expanded erythroid progenitor cells.

Sasaki S, Inoguchi T, Muta K, Abe Y, Zhang M, Hiasa K, Egashira K, Sonoda N, Kobayashi K, Takayanagi R, Nawata H.

Am J Physiol Heart Circ Physiol. 2007 Jan;292(1):H657-65. Epub 2006 Sep 22.

Supplemental Content

Support Center